This paper reviews the substantial body of literature emerging since 2004 concerning photonic nanojets. The photonic nanojet is a narrow, high-intensity, non-evanescent light beam that can propagate over a distance longer than the wavelength λ after emerging from the shadow-side surface of an illuminated lossless dielectric microcylinder or microsphere of diameter larger than λ. The nanojet’s minimum beamwidth can be smaller than the classical diffraction limit, in fact as small as ~λ/3 for microspheres. It is a nonresonant phenomenon appearing for a wide range of diameters of the microcylinder or microsphere if the refractive index contrast relative to the background is less than about 2:1. Importantly, inserting within a nanojet a nanoparticle of diameter dν perturbs the far-field backscattered power of the illuminated microsphere by an amount that varies as dν3 for a fixed λ. This perturbation is much slower than the dν6 dependence of Rayleigh scattering for the same nanoparticle, if isolated. This leads to a situation where, for example, the measured far-field backscattered power of a 3-μm diameter microsphere could double if a 30-nm diameter nanoparticle were inserted into the nanojet emerging from the microsphere, despite the nanoparticle having only 1/10,000th the cross-section area of the microsphere. In effect, the nanojet serves to project the presence of the nanoparticle to the far field. These properties combine to afford potentially important applications of photonic nanojets for detecting and manipulating nanoscale objects, subdiffraction-resolution nanopatterning and nanolithography, low-loss waveguiding, and ultrahigh-density optical storage.
Sample entropy, a nonlinear signal processing approach, was used as a measure of signal complexity to evaluate the cyclic behavior of heart rate variability (HRV) in obstructive sleep apnea syndrome (OSAS). In a group of 10 normal and 25 OSA subjects, the sample entropy measure showed that normal subjects have significantly more complex HRV pattern than the OSA subjects (p < 0.005). When compared with spectral analysis in a minute-by-minute classification, sample entropy had an accuracy of 70.3% (69.5% sensitivity, 70.8% specificity) while the spectral analysis had an accuracy of 70.4% (71.3% sensitivity, 69.9% specificity). The combination of the two methods improved the accuracy to 72.9% (72.2% sensitivity, 73.3% specificity). The sample entropy approach does not show major improvement over the existing methods. In fact, its accuracy in detecting sleep apnea is relatively low in the well classified data of the physionet. Its main achievement however, is the simplicity of computation. Sample entropy and other nonlinear methods might be useful tools to detect apnea episodes during sleep.
Temporary postoperative cardiac pacing requires devices with percutaneous leads and external wired power and control systems. This hardware introduces risks for infection, limitations on patient mobility, and requirements for surgical extraction procedures. Bioresorbable pacemakers mitigate some of these disadvantages, but they demand pairing with external, wired systems and secondary mechanisms for control. We present a transient closed-loop system that combines a time-synchronized, wireless network of skin-integrated devices with an advanced bioresorbable pacemaker to control cardiac rhythms, track cardiopulmonary status, provide multihaptic feedback, and enable transient operation with minimal patient burden. The result provides a range of autonomous, rate-adaptive cardiac pacing capabilities, as demonstrated in rat, canine, and human heart studies. This work establishes an engineering framework for closed-loop temporary electrotherapy using wirelessly linked, body-integrated bioelectronic devices.
BACKGROUND Atrial fibrillation is usually thought of as a "random" pattern of circulating wavelets. However, local atrial activation should be influenced by the constant anatomy and receding tail of refractoriness from the previous activation. The general tendency for wave fronts to follow paths of previous excitation has been termed "linking." We examined intra-atrial electrograms recorded during atrial fibrillation for evidence of linking. METHODS AND RESULTS Two minutes of atrial fibrillation were recorded in 15 patients with an orthogonal catheter. We have previously demonstrated that this catheter can be used to detect changes in the direction of local atrial activation. A mean vector was calculated for each electrogram. The similarity of the direction of the vectors from two consecutive electrograms can be quantified on a scale of 1 to -1 by calculating the cosine (cos) of the smallest angle (theta) between them. Two vectors pointing in the same or opposite directions then have cos(theta) = 1 or -1, respectively. For the entire group of patients, mean cos(theta) was significantly greater than 0 (mean, 0.36; p less than 0.001). In nine of 15 patients, there were groups of six or more consecutive beats (total, 44 groups; range, six to 14 beats per group) in which the direction of activation of each beat was within 30 degrees of the previous beat. The likelihood of one group of six or 14 consecutive similar beats occurring by chance in any one patient in 1 minute is less than 0.05 and less than 0.0000001, respectively. There was a significant correlation (r = 0.90) between the amount of linking during the first and second minutes of atrial fibrillation in each patient. CONCLUSIONS Transient similarities in the direction of wavelet propagation in the majority of patients with atrial fibrillation is consistent with the presence of transient linking. To our knowledge, this is the first direct evidence that atrial activation during atrial fibrillation in humans is not entirely random.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.